The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 16, 2022

Filed:

Dec. 30, 2019
Applicant:

Complete Genomics, Inc., San Jose, CA (US);

Inventor:

Radoje Drmanac, Los Altos Hills, CA (US);

Assignee:

Complete Genomics, Inc., San Jose, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/6869 (2018.01); C12Q 1/6806 (2018.01); C12Q 1/6874 (2018.01); C12Q 1/682 (2018.01); C12Q 1/6837 (2018.01); C07H 21/04 (2006.01); C07K 1/04 (2006.01); G01N 15/14 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6874 (2013.01); C07H 21/04 (2013.01); C07K 1/047 (2013.01); C12Q 1/682 (2013.01); C12Q 1/6806 (2013.01); C12Q 1/6837 (2013.01); C12Q 1/6869 (2013.01); G01N 15/1404 (2013.01); G01N 15/1434 (2013.01); C12Q 2525/151 (2013.01); C12Q 2525/313 (2013.01); C12Q 2531/125 (2013.01); C12Q 2565/513 (2013.01); Y10S 977/778 (2013.01); Y10S 977/789 (2013.01); Y10S 977/792 (2013.01); Y10S 977/88 (2013.01); Y10S 977/882 (2013.01);
Abstract

The invention provides methods and kits for ordering sequence information derived from one or more target polynucleotides. In one aspect, one or more tiers or levels of fragmentation and aliquoting are generated, after which sequence information is obtained from fragments in a final level or tier. Each fragment in such final tier is from a particular aliquot, which, in turn, is from a particular aliquot of a prior tier, and so on. For every fragment of an aliquot in the final tier, the aliquots from which it was derived at every prior tier is known, or can be discerned. Thus, identical sequences from overlapping fragments from different aliquots can be distinguished and grouped as being derived from the same or different fragments from prior tiers. When the fragments in the final tier are sequenced, overlapping sequence regions of fragments in different aliquots are used to register the fragments so that non-overlapping regions are ordered. In one aspect, this process is carried out in a hierarchical fashion until the one or more target polynucleotides are characterized, e.g. by their nucleic acid sequences, or by an ordering of sequence segments, or by an ordering of single nucleotide polymorphisms (SNPs), or the like.


Find Patent Forward Citations

Loading…